You are here

Prescription: Washington

Senate May Compromise on ‘Biosimilars’

Stephen Barlas
PDF version: 
Stephen Barlas discusses the possible passage of a Senate bill that would allow the FDA to approve "near copies" of biotech agents ("biosimilars").